DYRK1A and early-onset autosomal dominant Alzheimer disease: DYRK1A gene dosage imbalance has been associated with multiple disorders affecting both cognitive ability and skeletal health, including Down syndrome (DS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington disease (HD) (Deboever et al., 2022).